14-day Premium Trial Subscription Try For FreeTry Free

Humana (HUM) to Support Eligible Medicaid Members in Louisiana

08:05pm, Tuesday, 15'th Feb 2022 Zacks Investment Research
Humana (HUM) is picked by the Louisiana Department of Health for a contract win to help serve the Medicaid members in Louisiana.

Centene (CNC) Boosts Presence in Louisiana With Contract Win

05:05pm, Tuesday, 15'th Feb 2022 Zacks Investment Research
Centene's (CNC) latest contract renewal tends to improve health outcomes of Medicaid members of Louisiana.
After years of a low interest rate environment, many investors have turned to equities not only for the growth potential but also for solid and dependable dividends, which help to provide an income st
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that Bruce D. Broussard, President and Chief Executive Officer, will make a presentation to investors at the 11th Annual SVB Leerink Global Healthcare Conference on Friday, February 18, 2022 at 11:20 a.m. Eastern time. A live audio webcast of the presentation will be available via Humanas Investor Relations page at humana.com. The company suggests webcast participants sign on approximately 15 minutes in advance of the pr
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that Bruce D. Broussard, President and Chief Executive Officer, will make a presentation to investors at the 11th Annual SVB L
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana earns top score in Human Rights Campaign Foundation’s 2022 corporate equality index

Why It's Time To Buy This Blue-Chip Dividend Growth Stock

03:30pm, Tuesday, 08'th Feb 2022 The Motley Fool
Investors looking for a growing stream of income should consider buying UnitedHealth Group.

Meta Platforms, Spotify fall; Humana, Ralph Lauren rise

09:31pm, Thursday, 03'rd Feb 2022 ABC News
Stocks that traded heavily or had substantial price changes Thursday: Meta Platforms, Spotify fall; Humana, Ralph Lauren rise

Cigna (CI) Q4 Earnings Beat on Robust Cigna Healthcare Unit

06:00pm, Thursday, 03'rd Feb 2022 Zacks Investment Research
Cigna's (CI) fourth-quarter results benefit from strong medical customer growth. A solid outlook for 2022 when compared to the 2021 level remains noteworthy.

Expert Ratings For Humana

03:27pm, Thursday, 03'rd Feb 2022 Benzinga
Analysts have provided the following ratings for Humana (NYSE: HUM ) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 3 6 0 0 Last 30D 0 1 0 0 0 1M Ago 0 2 2 0 0 2M Ago 0 0 3 0 0 3M Ago 1 0 1 0 0 According to 10 analyst offering 12-month price targets in the last 3 months, Humana has an average price target of $490.5 with a high of $530.00 and a low of $410.00. Below is a summary of how these 10 analysts rated Humana over the past 3 months. The … Full story available on Benzinga.com

Company News for Feb 3, 2022

01:32pm, Thursday, 03'rd Feb 2022 Zacks Investment Research
Companies In The News Are: DHI, TMO, HUM, MPC.
Pre-open movers U.S. stock futures traded mostly lower in early pre-market trade following downbeat quarterly earnings from Meta Platforms, Inc. (NASDAQ: FB). Investors are awaiting earnings results

Humana (HUM) Q4 Earnings Beat Estimates on Membership Growth

05:43pm, Wednesday, 02'nd Feb 2022 Zacks Investment Research
Humana (HUM) is taking multiple initiatives like cost savings and others to generate $1 billion additional value to fund the Medicare Advantage business and boost Healthcare Services capabilities.

Did The Smart Money Play Humana Inc (HUM) Correctly?

04:10pm, Wednesday, 02'nd Feb 2022 Insider Monkey
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE